Efficacy of growth hormone in children with short stature complicated with benign thyroid nodules
ZHU Yanli1,2, TANG Aimei1, GU Qi1, TAN Juan1, LI Yue′e1, XU Yuanyuan3, WANG Jie3, TANG Yongquan3, ZHOU Wendi1,3
(1. Department of Pediatrics, Huai′an Clinical College of Xuzhou Medical University, Huai′an Jiangsu 223300; 2. Department of Pediatrics, Lianshui People′s Hospital of Kangda College Affiliated to Nanjing Medical University, Huai′an Jiangsu 223400; 3. Department of Pediatrics,the Affiliated Huai′an No.1 People′s Hospital of Nanjing Medical University， Huai′an Jiangsu 223300, China)
Abstract：Objective： To observe the effect of growth hormone on children with short stature complicated with benign thyroid nodules. Methods： Forty-seven children with short stature complicated with benign thyroid nodules who received growth hormone treatment in the Department of Pediatrics, Huai′an Clinical College of Xuzhou Medical University from January 2021 to October 2022 were selected as the treatment group. Thirty short stature children whose parents refused to receive growth hormone treatment were randomly selected as the control group. The changes of height and thyroid function were observed at the first visit, the 6th month and the 12th month. Results： The height and growth rate were significantly increased and the height standard deviation scores (HtSDS) were improved after 6 and 12 months treatment with growth hormone, the levels of insulinlike growth factor-1 (IGF-1) were significantly higher than those in the controls (P<0.05). In the control group, the height at the 6th and 12th month of follow-up was higher than that at the first visit (P<0.05), but the increase was not as significant as that in the treatment group. Growth rate, HtSDS and IGF-1 levels had no significant changes before and after re-diagnosis. In the treatment group, the maximum cross-sectional diameter and grade of benign thyroid nodule had no significant change after treatment (P>0.05), and the level of FT4 had no significant difference before and after treatment, the levels of TSH and FT3 were in the normal range after treatment. Conclusion： Growth hormone therapy could effectively improve the height of short children with benign thyroid nodules, and produce no significant effect on benign thyroid nodules. It is recommended to use growth hormone therapy for such children.
朱艳丽1,2，汤爱梅1，谷奇1，谭娟1，李月娥1，许媛媛3，王婕3，汤涌泉3，周文娣1,3. 矮身材合并良性甲状腺结节患儿使用生长激素疗效观察[J]. 江苏大学学报:医学版, 2023, 33(04): 338-342.
ZHU Yanli1,2, TANG Aimei1, GU Qi1, TAN Juan1, LI Yue′e1, XU Yuanyuan3, WANG Jie3, TANG Yongquan3, ZHOU Wendi1,3. Efficacy of growth hormone in children with short stature complicated with benign thyroid nodules. Journal of Jiangsu University(Medicine Edition), 2023, 33(04): 338-342.
